ARGLU1 in Glioma: A Novel Potential Regulator of Splicing, DNA Repair, and Therapeutic Resistance

Xi Wu, Dongye Yi, Dongjun Tie, Mengqi Du, Meiying Wang, Zhuang Yu, Younian Xu · 2026

Read ARGLU1 in Glioma: A Novel Potential Regulator of Splicing, DNA Repair, and Therapeutic Resistance by Xi Wu, Dongye Yi, Dongjun Tie, Mengqi Du, Meiying Wang, Zhuang Yu, Younian Xu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13297544.txt.

Description

One nuclear protein may sit at the crossroads of gene splicing and DNA repair in glioma, proposes a 2026 review led by Xi Wu. The protein, ARGLU1, is presented as a possible hub linking RNA polymerase II pausing, spliceosome activity, and homologous recombination in the most common malignant brain tumor.

Stronger repair through BRCA2 and RAD51 could help tumors withstand temozolomide chemotherapy and radiation, and ARGLU1 levels might predict who responds to PARP inhibitors. The authors are candid that direct glioma evidence remains limited and validation in glioma cohorts is still missing. Because the protein is intrinsically disordered, they suggest degrader strategies such as PROTACs as a route to drug it.

Catalog record

CREATORXi Wu, Dongye Yi, Dongjun Tie, Mengqi Du, Meiying Wang, Zhuang Yu, Younian Xu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49909
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13297544

Browse the full library · About the Tower of Babel